We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
Cap. Flow
+$1.17B
Cap. Flow %
9.66%
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$197M
2
BABA icon
Alibaba
BABA
+$190M
3
AMZN icon
Amazon
AMZN
+$161M
4
GDDY icon
GoDaddy
GDDY
+$135M
5
DIS icon
Walt Disney
DIS
+$132M

Sector Composition

Rank Sector Weight
1 Healthcare 24.88%
2 Consumer Discretionary 23.99%
3 Technology 11.1%
4 Financials 8.14%
5 Industrials 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFNX
1276
DELISTED
Pfenex Inc.
PFNX
$80K ﹤0.01%
+11,819
New +$75.5K
LTS
1277
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$70K ﹤0.01%
20,394
-198,291
-91% -$685K
MNTX
1278
DELISTED
Manitex International, Inc.
MNTX
$68K ﹤0.01%
+11,107
New +$75.8K
CMRE icon
1279
Costamare
CMRE
$1.87B
$67K ﹤0.01%
+13,147
New +$72.1K
PBPB
1280
DELISTED
Potbelly
PBPB
$66K ﹤0.01%
+12,888
New +$87.5K
AKRX
1281
DELISTED
Akorn Inc
AKRX
$66K ﹤0.01%
12,771
-235,365
-95% -$906K
CBB
1282
DELISTED
Cincinnati Bell Inc.
CBB
$64K ﹤0.01%
+12,979
New +$99.6K
ABEO icon
1283
Abeona Therapeutics
ABEO
$349M
$63K ﹤0.01%
530
+167
+46% +$28K
OPK icon
1284
Opko Health
OPK
$929M
$59K ﹤0.01%
36,965
-1,415,211
-97% -$3.09M
XIN
1285
DELISTED
Xinyuan Real Estate
XIN
$45K ﹤0.01%
1,078
-11,779
-92% -$529K
HYG icon
1286
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$43K ﹤0.01%
+500
New +$43.2K
MFG icon
1287
Mizuho Financial
MFG
$129B
$37K ﹤0.01%
+12,957
New +$38.4K
USO icon
1288
PUT
United States Oil Fund
USO
$2.12B
$15K ﹤0.01%
+163
New +$16.3K
LPSN icon
1289
LivePerson
LPSN
$20.1M
$3K ﹤0.01%
+698
New +$298K
AA icon
1290
Alcoa
AA
$11.6B
-343,969
Closed -$9.69M
AAP icon
1291
Advance Auto Parts
AAP
$3.42B
-60,966
Closed -$10.4M
ABEV icon
1292
Ambev
ABEV
$47B
-1,976,634
Closed -$8.5M
AC
1293
DELISTED
Associated Capital Group
AC
-6,869
Closed -$270K
ACET icon
1294
Adicet Bio
ACET
$73.3M
-28
Closed -$21K
ACIW icon
1295
ACI Worldwide
ACIW
$5.86B
-1,500
Closed -$49K
ACMR icon
1296
ACM Research
ACMR
$5.42B
-4,557
Closed -$23K
ACN icon
1297
Accenture
ACN
$93.6B
-10,658
Closed -$1.88M
ACRS icon
1298
Aclaris Therapeutics
ACRS
$763M
-17,245
Closed -$103K
ACTG icon
1299
Acacia Research
ACTG
$442M
-51,631
Closed -$168K
ADM icon
1300
Archer Daniels Midland
ADM
$40.3B
-529,696
Closed -$22.8M

Similar funds

Marshall Wace's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.

  • Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
  • Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
  • Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
  • Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
  • Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
  • Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.

Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.